Antinociceptive effect of intrathecally-administered desipramine and zimelidine in rats.
The effect of intrathecally (i.th.) administered desipramine and zimelidine, in doses of 5, 10 and 50 micrograms, were investigated in the tail-flick test with simultaneous measurement of the temperature of the tail skin and in the increasing temperature hot-plate test. A constant negative correlation between the temperature of the tail skin and tail-flick latency, as described previously, was found. For all doses tested, desipramine induced longer tail-flick latencies, 10 min after injection than vehicle and the temperature of the tail skin tended to increase less in this group than in controls. After adjustment of the tail-flick latencies for the changes in the temperature of the tail skin, an antinociceptive effect of desipramine was still found. For zimelidine, only the largest dose (50 micrograms) was found to be antinociceptive, after adjustment for the tail skin temperature. In the increasing temperature hot-plate test, no antinociceptive effect of these antidepressants was found. For desipramine and zimelidine, the effect in the tail-flick test, 10 min after injection, indicates that the antinociceptive effect of these drugs may have, at least partly, a spinal site of action. In the increasing temperature hot-plate test, the response is integrated supraspinally. This may partly explain the lack of effect in this test when desipramine and zimelidine were administered intrathecally.
Lund
A
A
Department of Physiology, University of Bergen, Norway.
Tjølsen
A
A
Hole
K
K
D000700:Analgesics; D000818:Animals; D003891:Desipramine / Q000008:administration & dosage / Q000494:pharmacology*; D007278:Injections, Spinal; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D011930:Reaction Time / Q000187:drug effects; D013696:Temperature; D015031:Zimeldine / Q000008:administration & dosage / Q000494:pharmacology*
D000700:Analgesics; D015031:Zimeldine; D003891:Desipramine